title: Chronic myeloid leukaemia presenting post-radiotherapy for prostate cancer: further evidence for an immunosurveillance effect.
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
authors.forename: Aine
authors.initials: A
authors.lastname: Burke
authors.forename: Sarah L
authors.initials: SL
authors.lastname: McCarron
authors.forename: Johanna
authors.initials: J
authors.lastname: Kelly
authors.forename: Peig
authors.initials: P
authors.lastname: Carroll
authors.forename: Paul V
authors.initials: PV
authors.lastname: Browne
authors.forename: Eibhlin
authors.initials: E
authors.lastname: Conneally
mesh_terms: D006801:Humans; D007157:Immunologic Surveillance / Q000528:radiation effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects
keywords: chronic myeloid leukaemia; immunosurveillance; prostate cancer; radiotherapy